25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vita Life Sciences Ltd
Buy, Hold or Sell?

Let's analyze Vita Life Sciences Ltd together

I guess you are interested in Vita Life Sciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vita Life Sciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vita Life Sciences Ltd

I send you an email if I find something interesting about Vita Life Sciences Ltd.

1. Quick Overview

1.1. Quick analysis of Vita Life Sciences Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Vita Life Sciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.16
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$0.77
Expected worth in 1 year
A$1.25
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
A$0.72
Return On Investment
35.1%

For what price can you sell your share?

Current Price per Share
A$2.06
Expected price per share
A$1.8913005102041 - A$2.16
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vita Life Sciences Ltd (5 min.)




Live pricePrice per Share (EOD)
A$2.06
Intrinsic Value Per Share
A$1.11 - A$2.86
Total Value Per Share
A$1.87 - A$3.63

2.2. Growth of Vita Life Sciences Ltd (5 min.)




Is Vita Life Sciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$28.5m$24m$4.4m15.8%

How much money is Vita Life Sciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money$5.9m$4.6m$1.3m22.0%
Net Profit Margin12.2%10.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Vita Life Sciences Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vita Life Sciences Ltd?

Welcome investor! Vita Life Sciences Ltd's management wants to use your money to grow the business. In return you get a share of Vita Life Sciences Ltd.

First you should know what it really means to hold a share of Vita Life Sciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Vita Life Sciences Ltd is A$2.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vita Life Sciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vita Life Sciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.77. Based on the TTM, the Book Value Change Per Share is A$0.12 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.06 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vita Life Sciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.115.1%0.115.1%0.084.0%0.083.8%0.063.1%
Usd Book Value Change Per Share0.083.9%0.083.9%0.073.4%0.052.4%0.031.5%
Usd Dividend Per Share0.041.9%0.041.9%0.041.7%0.031.5%0.031.3%
Usd Total Gains Per Share0.125.8%0.125.8%0.115.2%0.083.9%0.062.9%
Usd Price Per Share1.17-1.17-0.89-0.88-0.83-
Price to Earnings Ratio11.06-11.06-10.79-11.21-14.53-
Price-to-Total Gains Ratio9.85-9.85-8.38-12.49--0.74-
Price to Book Ratio2.32-2.32-2.09-2.38-2.66-
Price-to-Total Gains Ratio9.85-9.85-8.38-12.49--0.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.356716
Number of shares737
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.040.03
Usd Book Value Change Per Share0.080.05
Usd Total Gains Per Share0.120.08
Gains per Quarter (737 shares)87.7458.89
Gains per Year (737 shares)350.96235.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111623534192144226
2232470692183288462
33487051043275432698
44649401394366576934
5580117517454587201170
6695141020965498641406
78111645244764110081642
89271880279873211521878
910432115314982412972114
1011592351350091514412350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.02.04.075.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%19.05.00.079.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%17.00.07.070.8%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%19.05.00.079.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vita Life Sciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1210.1210%0.108+12%0.074+63%0.048+152%
Book Value Per Share--0.7680.7680%0.647+19%0.558+38%0.482+60%
Current Ratio--2.9782.9780%2.770+8%2.508+19%2.875+4%
Debt To Asset Ratio--0.2750.2750%0.295-7%0.331-17%0.314-12%
Debt To Equity Ratio--0.3800.3800%0.418-9%0.498-24%0.464-18%
Dividend Per Share--0.0600.0600%0.054+11%0.047+27%0.041+44%
Eps--0.1610.1610%0.126+28%0.119+35%0.096+68%
Free Cash Flow Per Share--0.2180.2180%0.134+63%0.122+79%0.081+169%
Free Cash Flow To Equity Per Share--0.1680.1680%0.079+113%0.065+157%0.034+394%
Gross Profit Margin---0.252-0.2520%-0.470+87%-0.399+59%-0.596+137%
Intrinsic Value_10Y_max--2.857--------
Intrinsic Value_10Y_min--1.107--------
Intrinsic Value_1Y_max--0.181--------
Intrinsic Value_1Y_min--0.090--------
Intrinsic Value_3Y_max--0.624--------
Intrinsic Value_3Y_min--0.289--------
Intrinsic Value_5Y_max--1.163--------
Intrinsic Value_5Y_min--0.509--------
Market Cap116182558.000+14%100390754.000100390754.0000%76421051.500+31%75631461.300+33%71303982.430+41%
Net Profit Margin--0.1220.1220%0.106+16%0.116+6%0.111+10%
Operating Margin--0.1650.1650%0.161+2%0.162+2%0.155+6%
Operating Ratio--0.8350.8350%0.840-1%0.845-1%0.847-1%
Pb Ratio2.681+14%2.3172.3170%2.094+11%2.383-3%2.664-13%
Pe Ratio12.795+14%11.05611.0560%10.788+2%11.214-1%14.533-24%
Price Per Share2.060+14%1.7801.7800%1.355+31%1.341+33%1.262+41%
Price To Free Cash Flow Ratio9.429+14%8.1478.1470%10.130-20%14.122-42%3.062+166%
Price To Total Gains Ratio11.396+14%9.8479.8470%8.381+17%12.491-21%-0.743+108%
Quick Ratio--2.2102.2100%1.919+15%1.959+13%2.270-3%
Return On Assets--0.1520.1520%0.137+11%0.143+6%0.135+13%
Return On Equity--0.2090.2090%0.194+8%0.212-1%0.196+7%
Total Gains Per Share--0.1810.1810%0.162+12%0.121+49%0.089+102%
Usd Book Value--28537796.60028537796.6000%24040875.800+19%20710862.480+38%17917213.000+59%
Usd Book Value Change Per Share--0.0800.0800%0.071+12%0.049+63%0.032+152%
Usd Book Value Per Share--0.5060.5060%0.426+19%0.367+38%0.317+60%
Usd Dividend Per Share--0.0390.0390%0.035+11%0.031+27%0.027+44%
Usd Eps--0.1060.1060%0.083+28%0.079+35%0.063+68%
Usd Free Cash Flow--8115269.2008115269.2000%4968478.400+63%4544866.880+79%3020339.600+169%
Usd Free Cash Flow Per Share--0.1440.1440%0.088+63%0.081+79%0.053+169%
Usd Free Cash Flow To Equity Per Share--0.1100.1100%0.052+113%0.043+157%0.022+394%
Usd Market Cap76517832.699+14%66117350.58466117350.5840%50330904.518+31%49810880.412+33%46960802.828+41%
Usd Price Per Share1.357+14%1.1721.1720%0.892+31%0.883+33%0.831+41%
Usd Profit--5980088.0005980088.0000%4665522.400+28%4437119.920+35%3556571.720+68%
Usd Revenue--48842434.60048842434.6000%44051119.600+11%37814309.320+29%31546413.120+55%
Usd Total Gains Per Share--0.1190.1190%0.106+12%0.080+49%0.059+102%
 EOD+4 -4MRQTTM+0 -0YOY+33 -35Y+33 -310Y+33 -3

3.3 Fundamental Score

Let's check the fundamental score of Vita Life Sciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1512.795
Price to Book Ratio (EOD)Between0-12.681
Net Profit Margin (MRQ)Greater than00.122
Operating Margin (MRQ)Greater than00.165
Quick Ratio (MRQ)Greater than12.210
Current Ratio (MRQ)Greater than12.978
Debt to Asset Ratio (MRQ)Less than10.275
Debt to Equity Ratio (MRQ)Less than10.380
Return on Equity (MRQ)Greater than0.150.209
Return on Assets (MRQ)Greater than0.050.152
Total9/10 (90.0%)

3.4 Technical Score

Let's check the technical score of Vita Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose2.090
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Vita Life Sciences Ltd

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.

Fundamental data was last updated by Penke on 2024-10-17 13:26:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vita Life Sciences Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.2% means that $0.12 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vita Life Sciences Ltd:

  • The MRQ is 12.2%. The company is making a huge profit. +2
  • The TTM is 12.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.2%TTM12.2%0.0%
TTM12.2%YOY10.6%+1.7%
TTM12.2%5Y11.6%+0.7%
5Y11.6%10Y11.1%+0.4%
4.3.1.2. Return on Assets

Shows how efficient Vita Life Sciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 15.2% Return on Assets means that Vita Life Sciences Ltd generated $0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vita Life Sciences Ltd:

  • The MRQ is 15.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 15.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ15.2%TTM15.2%0.0%
TTM15.2%YOY13.7%+1.5%
TTM15.2%5Y14.3%+0.9%
5Y14.3%10Y13.5%+0.8%
4.3.1.3. Return on Equity

Shows how efficient Vita Life Sciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.9% Return on Equity means Vita Life Sciences Ltd generated $0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vita Life Sciences Ltd:

  • The MRQ is 20.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 20.9%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ20.9%TTM20.9%0.0%
TTM20.9%YOY19.4%+1.6%
TTM20.9%5Y21.2%-0.2%
5Y21.2%10Y19.6%+1.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vita Life Sciences Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vita Life Sciences Ltd is operating .

  • Measures how much profit Vita Life Sciences Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 16.5% means the company generated $0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vita Life Sciences Ltd:

  • The MRQ is 16.5%. The company is operating efficient. +1
  • The TTM is 16.5%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ16.5%TTM16.5%0.0%
TTM16.5%YOY16.1%+0.4%
TTM16.5%5Y16.2%+0.3%
5Y16.2%10Y15.5%+0.7%
4.3.2.2. Operating Ratio

Measures how efficient Vita Life Sciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are $0.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vita Life Sciences Ltd:

  • The MRQ is 0.835. The company is less efficient in keeping operating costs low.
  • The TTM is 0.835. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.835TTM0.8350.000
TTM0.835YOY0.840-0.004
TTM0.8355Y0.845-0.009
5Y0.84510Y0.847-0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vita Life Sciences Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vita Life Sciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.98 means the company has $2.98 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vita Life Sciences Ltd:

  • The MRQ is 2.978. The company is able to pay all its short-term debts. +1
  • The TTM is 2.978. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.978TTM2.9780.000
TTM2.978YOY2.770+0.208
TTM2.9785Y2.508+0.470
5Y2.50810Y2.875-0.367
4.4.3.2. Quick Ratio

Measures if Vita Life Sciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.21 means the company can pay off $2.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vita Life Sciences Ltd:

  • The MRQ is 2.210. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.210. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.210TTM2.2100.000
TTM2.210YOY1.919+0.292
TTM2.2105Y1.959+0.252
5Y1.95910Y2.270-0.312
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vita Life Sciences Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vita Life Sciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vita Life Sciences Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that Vita Life Sciences Ltd assets are financed with 27.5% credit (debt) and the remaining percentage (100% - 27.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vita Life Sciences Ltd:

  • The MRQ is 0.275. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.275. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.275TTM0.2750.000
TTM0.275YOY0.295-0.020
TTM0.2755Y0.331-0.056
5Y0.33110Y0.314+0.017
4.5.4.2. Debt to Equity Ratio

Measures if Vita Life Sciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 38.0% means that company has $0.38 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vita Life Sciences Ltd:

  • The MRQ is 0.380. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.380. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.380TTM0.3800.000
TTM0.380YOY0.418-0.039
TTM0.3805Y0.498-0.119
5Y0.49810Y0.464+0.035
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vita Life Sciences Ltd generates.

  • Above 15 is considered overpriced but always compare Vita Life Sciences Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.06 means the investor is paying $11.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vita Life Sciences Ltd:

  • The EOD is 12.795. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.056. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.056. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD12.795MRQ11.056+1.739
MRQ11.056TTM11.0560.000
TTM11.056YOY10.788+0.268
TTM11.0565Y11.214-0.158
5Y11.21410Y14.533-3.319
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vita Life Sciences Ltd:

  • The EOD is 9.429. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 8.147. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 8.147. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD9.429MRQ8.147+1.282
MRQ8.147TTM8.1470.000
TTM8.147YOY10.130-1.983
TTM8.1475Y14.122-5.975
5Y14.12210Y3.062+11.060
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vita Life Sciences Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Vita Life Sciences Ltd:

  • The EOD is 2.681. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.317. Based on the equity, the company is underpriced. +1
  • The TTM is 2.317. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.681MRQ2.317+0.364
MRQ2.317TTM2.3170.000
TTM2.317YOY2.094+0.223
TTM2.3175Y2.383-0.067
5Y2.38310Y2.664-0.280
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vita Life Sciences Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Total Other Income Expense Net -146-20-16661-10571-34270236



5.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets59,807
Total Liabilities16,476
Total Stockholder Equity43,397
 As reported
Total Liabilities 16,476
Total Stockholder Equity+ 43,397
Total Assets = 59,807

Assets

Total Assets59,807
Total Current Assets48,289
Long-term Assets11,518
Total Current Assets
Cash And Cash Equivalents 24,630
Net Receivables 11,215
Inventory 11,153
Other Current Assets 1,291
Total Current Assets  (as reported)48,289
Total Current Assets  (calculated)48,289
+/-0
Long-term Assets
Property Plant Equipment 9,170
Intangible Assets 26
Long-term Assets Other 2,348
Long-term Assets  (as reported)11,518
Long-term Assets  (calculated)11,544
+/- 26

Liabilities & Shareholders' Equity

Total Current Liabilities16,216
Long-term Liabilities260
Total Stockholder Equity43,397
Total Current Liabilities
Short-term Debt 211
Accounts payable 5,579
Other Current Liabilities 6,331
Total Current Liabilities  (as reported)16,216
Total Current Liabilities  (calculated)12,121
+/- 4,095
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt176
Long-term Liabilities  (as reported)260
Long-term Liabilities  (calculated)176
+/- 84
Total Stockholder Equity
Common Stock42,567
Retained Earnings -2,769
Accumulated Other Comprehensive Income 3,599
Total Stockholder Equity (as reported)43,397
Total Stockholder Equity (calculated)43,397
+/-0
Other
Capital Stock42,567
Cash and Short Term Investments 24,630
Common Stock Shares Outstanding 54,692
Current Deferred Revenue4,095
Liabilities and Stockholders Equity 59,807
Net Debt -24,243
Net Invested Capital 43,397
Net Working Capital 32,073
Property Plant and Equipment Gross 12,120
Short Long Term Debt Total 387



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
48,948
66,052
34,146
19,597
19,011
15,948
12,959
6,729
8,641
8,810
14,512
13,349
16,813
22,009
30,271
32,388
32,359
32,954
35,720
36,513
39,104
45,270
51,799
59,807
59,80751,79945,27039,10436,51335,72032,95432,35932,38830,27122,00916,81313,34914,5128,8108,6416,72912,95915,94819,01119,59734,14666,05248,948
   > Total Current Assets 
0
0
0
0
0
0
0
4,655
6,216
6,603
12,227
10,926
15,579
20,491
20,809
23,524
21,749
22,308
24,797
25,760
29,191
35,103
41,157
48,289
48,28941,15735,10329,19125,76024,79722,30821,74923,52420,80920,49115,57910,92612,2276,6036,2164,6550000000
       Cash And Cash Equivalents 
3,864
804
1,545
680
967
993
1,931
616
1,293
1,076
456
3,632
5,017
8,973
9,158
9,734
9,411
9,965
10,941
10,478
14,477
15,893
15,688
24,630
24,63015,68815,89314,47710,47810,9419,9659,4119,7349,1588,9735,0173,6324561,0761,2936161,9319939676801,5458043,864
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,637
1,714
4,321
0
2,108
4,382
5,990
3,846
0
03,8465,9904,3822,10804,3211,7141,637000000000000000
       Net Receivables 
28,751
41,541
5,897
2,284
3,155
3,591
4,890
1,929
2,145
2,803
8,086
3,285
4,481
4,730
6,041
6,482
6,234
6,662
7,093
7,760
6,942
7,117
8,977
11,215
11,2158,9777,1176,9427,7607,0936,6626,2346,4826,0414,7304,4813,2858,0862,8032,1451,9294,8903,5913,1552,2845,89741,54128,751
       Other Current Assets 
904
375
1,379
844
1,432
529
4,128
64
61
65
84
74
87
132
188
309
242
215
189
263
254
306
473
1,291
1,2914733062542631892152423091881328774846561644,1285291,4328441,379375904
   > Long-term Assets 
0
0
0
0
0
0
0
2,074
2,424
2,207
2,286
2,424
1,234
1,518
9,462
8,864
10,610
10,646
10,923
10,753
9,913
10,167
10,642
11,518
11,51810,64210,1679,91310,75310,92310,64610,6108,8649,4621,5181,2342,4242,2862,2072,4242,0740000000
       Property Plant Equipment 
489
3,237
3,161
2,391
2,012
1,245
211
274
303
193
223
193
199
369
6,910
7,629
9,381
9,409
8,642
9,139
8,372
8,264
8,472
9,170
9,1708,4728,2648,3729,1398,6429,4099,3817,6296,9103691991932231933032742111,2452,0122,3913,1613,237489
       Goodwill 
4,332
10,694
0
7,678
7,310
6,240
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000006,2407,3107,678010,6944,332
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,022
1,044
937
925
947
1,043
0
0
0
0
0
000001,0439479259371,0441,0220000000000000
       Intangible Assets 
5,349
10,919
10,448
7,678
7,310
6,240
78
73
0
0
0
0
0
0
97
86
76
60
71
12
12
0
10
26
261001212716076869700000073786,2407,3107,67810,44810,9195,349
       Long-term Assets Other 
0
0
0
0
0
0
0
1,640
623
490
478
465
0
210
0
5
23
7
10,923
1,614
1,541
0
2,170
2,348
2,3482,17001,5411,61410,9237235021004654784906231,6400000000
> Total Liabilities 
20,004
25,870
20,689
28,924
29,206
29,731
15,100
3,849
4,795
4,909
6,382
4,393
5,471
5,740
8,706
9,512
9,184
8,161
13,313
13,979
14,661
14,847
15,296
16,476
16,47615,29614,84714,66113,97913,3138,1619,1849,5128,7065,7405,4714,3936,3824,9094,7953,84915,10029,73129,20628,92420,68925,87020,004
   > Total Current Liabilities 
19,604
24,662
16,462
11,751
11,874
11,108
15,088
3,845
4,779
4,891
6,377
4,365
5,422
5,684
5,534
6,869
6,847
6,079
11,393
12,116
13,038
14,461
14,860
16,216
16,21614,86014,46113,03812,11611,3936,0796,8476,8695,5345,6845,4224,3656,3774,8914,7793,84515,08811,10811,87411,75116,46224,66219,604
       Short-term Debt 
0
0
0
0
0
0
0
818
1,278
1,321
1,814
0
0
0
260
243
279
290
342
644
617
190
300
211
2113001906176443422902792432600001,8141,3211,2788180000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
260
243
279
290
342
364
343
0
0
0
00034336434229027924326000000000000000
       Accounts payable 
17,362
6,930
0
4,530
3,225
3,143
1,617
1,330
2,164
1,945
2,685
2,267
2,423
1,986
1,929
2,849
1,287
2,455
2,563
2,526
3,088
3,819
4,495
5,579
5,5794,4953,8193,0882,5262,5632,4551,2872,8491,9291,9862,4232,2672,6851,9452,1641,3301,6173,1433,2254,53006,93017,362
       Other Current Liabilities 
2,164
14,869
13,597
5,999
6,570
5,010
5,313
1,697
1,337
1,625
1,879
2,098
2,999
3,698
3,345
3,777
5,281
3,334
4,722
4,575
4,025
3,515
6,166
6,331
6,3316,1663,5154,0254,5754,7223,3345,2813,7773,3453,6982,9992,0981,8791,6251,3371,6975,3135,0106,5705,99913,59714,8692,164
   > Long-term Liabilities 
0
0
0
0
0
0
0
5
16
19
5
28
49
56
3,172
2,643
2,337
2,082
1,920
1,863
1,623
386
436
260
2604363861,6231,8631,9202,0822,3372,6433,1725649285191650000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,567
2,181
1,927
1,732
1,705
1,455
183
301
0
03011831,4551,7051,7321,9272,1812,567000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
-818
-1,278
-1,321
-1,814
0
0
0
-260
-243
-279
-290
-342
-60
-49
183
301
176
176301183-49-60-342-290-279-243-260000-1,814-1,321-1,278-8180000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
83
97
86
76
60
71
12
12
0
0
0
00012127160768697830000000000000
> Total Stockholder Equity
28,932
40,182
13,473
0
0
0
0
2,403
3,223
3,411
7,651
8,491
11,256
16,179
21,469
22,826
23,133
24,758
22,375
22,599
24,721
30,753
36,574
43,397
43,39736,57430,75324,72122,59922,37524,75823,13322,82621,46916,17911,2568,4917,6513,4113,2232,403000013,47340,18228,932
   Common Stock
24,456
37,818
37,818
37,831
38,081
38,081
38,979
44,280
44,550
45,699
45,690
45,568
45,956
46,100
45,429
44,911
44,692
44,498
43,742
42,249
41,593
41,633
41,904
42,567
42,56741,90441,63341,59342,24943,74244,49844,69244,91145,42946,10045,95645,56845,69045,69944,55044,28038,97938,08138,08137,83137,81837,81824,456
   Retained Earnings 
2,927
479
0
0
0
0
0
-40,450
-40,428
-40,757
-36,297
-35,355
-33,532
-29,623
-24,307
-21,863
-20,590
-19,789
-23,243
-22,046
-17,925
-12,528
-8,482
-2,769
-2,769-8,482-12,528-17,925-22,046-23,243-19,789-20,590-21,863-24,307-29,623-33,532-35,355-36,297-40,757-40,428-40,450000004792,927
   Capital Surplus 000000000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347
-1,180
-969
49
1,876
2,396
1,053
1,648
201
859
8592011,6481,0532,3961,87649-969-1,18034700000000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.